Physician

Matthew Lloyd Tate, MD

According to 2025 Medicare claims, Matthew Tate, MD (NPI: 1508089426) practices radiation oncology in the Muskegon-Norton Shores, MI market, with the plurality of this provider's patient population coming from Muskegon, MI. This provider's primary affiliated billing organization is JOHNSON FAMILY CENTER FOR CANCER CARE (NPI: 1639368293; TIN: 470859270) and primary practice location at 49444-1816. Tate is affiliated with the Trinity Health Integrated Care (ACO ID: A3454), participating under the MSSP model.

Tate's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 102 traditional Medicare patients, billed 1,227 HCPCS/CPT codes, and received $145,212 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 149 prescription claims across 69 beneficiaries totaling $2,375 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2018 DME data shows 48 claims. Open Payments data shows 1 records totaling $101. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $983,050 to $145,212. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $4,754 to $2,375. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.